The Resistance Landscape of Uropathogens in a Romanian Tertiary Center: A 13-Month Single-Center Study with Focus on Klebsiella and Urease-Positive Organisms
Abstract
Urinary tract infections (UTIs) sit at a leading edge of the antimicrobial-resistance (AMR) crisis, and Romania ranks among the most affected European countries, yet large single-center series of urinary isolates with complete antibiograms remain scarce. We describe the full resistance landscape of urinary pathogens at a Romanian tertiary hospital, with particular attention to multidrug-resistant Klebsiella and to the often-overlooked urease-positive organisms. We analyzed all positive urine cultures processed over 13 consecutive months (February 2025-February 2026). The first isolate per patient was the primary unit of analysis (n = 2331); the full isolate-level dataset (n = 3348) was analyzed secondarily. Resistance phenotypes (putative ESBL, carbapenem resistance, MDR, VRE) were derived from per-agent susceptibility data following Magiorakos et al., and resistance rates were calculated only on tested isolates. Associations were tested with chi-square/Fisher tests and Benjamini-Hochberg correction. A total of 3348 isolates from 2331 unique patients were analyzed (median age 68 years; 55% male). Escherichia coli predominated (40.5%), followed by Enterococcus spp. (22.2%) and Klebsiella spp. (18.9%). Among the first isolates, 15.3% were MDR; 16.7% of E. coli, Klebsiella and Proteus showed a putative ESBL phenotype; and 3.9% of Enterobacterales were carbapenem-resistant. Resistance was concentrated in Klebsiella (36.2% MDR, 22.8% putative ESBL, 14.7% carbapenem-resistant; all…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.